Arkolith/Insider Trading/NXL/Form 4

Owens David

Chief Medical Officer, DirectorNexalin Technology, Inc. (NXL) · full profile →Form 4 · filed Feb 27, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2025Grant(A)140K—$0140K
Feb 26, 2025Grant(A)125K—$0919K
Feb 26, 2025Grant(A)654K—$0794K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-25-001254) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML